Cargando…

(18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy

BACKGROUND: Quantitative image analysis based on radiomic feature extraction is an emerging field for survival prediction in oncological patients. (18)F-Fluorethyltyrosine positron emission tomography ((18)F-FET PET) provides important diagnostic and grading information for brain tumors, but data on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiltgen, Tun, Fleischmann, Daniel F., Kaiser, Lena, Holzgreve, Adrien, Corradini, Stefanie, Landry, Guillaume, Ingrisch, Michael, Popp, Ilinca, Grosu, Anca L., Unterrainer, Marcus, Bartenstein, Peter, Parodi, Katia, Belka, Claus, Albert, Nathalie, Niyazi, Maximilian, Riboldi, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719240/ https://www.ncbi.nlm.nih.gov/pubmed/36461120 http://dx.doi.org/10.1186/s13014-022-02164-6

Ejemplares similares

FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?
por: Carles, Montserrat, et al.
Publicado: (2021)

Can Radiomics Provide Additional Information in [(18)F]FET-Negative Gliomas?
por: von Rohr, Katharina, et al.
Publicado: (2022)

Combination of pre-treatment dynamic [(18)F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma
por: Li, Zhicong, et al.
Publicado: (2022)

Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [(18)F]FET PET radiomics
por: Li, Zhicong, et al.
Publicado: (2021)

(18)F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors
por: Mittlmeier, Lena M., et al.
Publicado: (2021)

Towards standardization of (18)F-FET PET imaging: do we need a consistent method of background activity assessment?
por: Unterrainer, Marcus, et al.
Publicado: (2017)

High-Grade Glioma Radiation Therapy and Reirradiation Treatment Planning Using Translocator Protein Positron Emission Tomography With (18)F-GE-180
por: Fleischmann, Daniel Felix, et al.
Publicado: (2023)

Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation
por: Fleischmann, Daniel F., et al.
Publicado: (2019)

Voxel-wise analysis of dynamic (18)F-FET PET: a novel approach for non-invasive glioma characterisation
por: Vomacka, Lena, et al.
Publicado: (2018)

Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches
por: Holzgreve, Adrien, et al.
Publicado: (2016)

The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation
por: Rühle, Alexander, et al.
Publicado: (2023)

Risk Stratification Using (18)F-FDG PET/CT and Artificial Neural Networks in Head and Neck Cancer Patients Undergoing Radiotherapy
por: Marschner, Sebastian N., et al.
Publicado: (2021)

Technical Issues of [(18)F]FET-PET Imaging for Radiation Therapy Planning in Malignant Glioma Patients – A Review
por: Walter, F., et al.
Publicado: (2012)

TERT-Promoter Mutational Status in Glioblastoma – Is There an Association With Amino Acid Uptake on Dynamic (18)F-FET PET?
por: Unterrainer, Marcus, et al.
Publicado: (2021)

External Validation of the Graded Prognostic Assessment in Patients with Brain Metastases from Small Cell Lung Cancer
por: Nieder, Carsten, et al.
Publicado: (2022)

Distant metastasis time to event analysis with CNNs in independent head and neck cancer cohorts
por: Lombardo, Elia, et al.
Publicado: (2021)

PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?
por: Popp, Ilinca, et al.
Publicado: (2023)

Predicting IDH genotype in gliomas using FET PET radiomics
por: Lohmann, Philipp, et al.
Publicado: (2018)

Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients
por: Gutsche, Robin, et al.
Publicado: (2021)

Validation of the graded prognostic assessment for gastrointestinal cancers with brain metastases (GI-GPA)
por: Nieder, Carsten, et al.
Publicado: (2020)

First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments
por: Combs, Stephanie E., et al.
Publicado: (2020)

Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?
por: Quach, Stefanie, et al.
Publicado: (2022)

Choline PET based dose-painting in prostate cancer - Modelling of dose effects
por: Niyazi, Maximilian, et al.
Publicado: (2010)

Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer
por: Szuecs, Marcella, et al.
Publicado: (2015)

Longitudinal [(18)F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse Model
por: Holzgreve, Adrien, et al.
Publicado: (2022)

L-type amino acid transporter (LAT) 1 expression in (18)F-FET-negative gliomas
por: Vettermann, Franziska J., et al.
Publicado: (2021)

Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost—tutorial and efficacy of complete directional hippocampal blocking
por: Popp, Ilinca, et al.
Publicado: (2022)

Assessment of intrafractional prostate motion and its dosimetric impact in MRI-guided online adaptive radiotherapy with gating
por: Xiong, Yuqing, et al.
Publicado: (2022)

(18)F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy
por: Carles, Montserrat, et al.
Publicado: (2021)

Suspected recurrence of brain metastases after focused high dose radiotherapy: can [(18)F]FET- PET overcome diagnostic uncertainties?
por: Romagna, Alexander, et al.
Publicado: (2016)

(68)Ga-EMP-100 PET/CT—a novel method for non-invasive assessment of c-MET expression in non-small cell lung cancer
por: Unterrainer, Lena M., et al.
Publicado: (2022)

The roles of glucose metabolic reprogramming in chemo- and radio-resistance
por: Lin, Jinguan, et al.
Publicado: (2019)

Single-isocenter stereotactic radiosurgery for multiple brain metastases: Impact of patient misalignments on target coverage in non-coplanar treatments
por: Eder, Michael Martin, et al.
Publicado: (2022)

Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
por: Spohn, Simon K. B., et al.
Publicado: (2023)

Deep learning based automatic segmentation of organs-at-risk for 0.35 T MRgRT of lung tumors
por: Ribeiro, Marvin F., et al.
Publicado: (2023)

Magnetic resonance-guided radiation therapy: the beginning of a new era
por: Landry, Guillaume, et al.
Publicado: (2020)

Recent advances of PET imaging in clinical radiation oncology
por: Unterrainer, M., et al.
Publicado: (2020)

Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression
por: Müller, Marguerite, et al.
Publicado: (2022)

De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers—HPV and Beyond
por: Rühle, Alexander, et al.
Publicado: (2021)

In response to: Anatomy of (18)F-GE180, a failed radioligand for the TSPO protein
por: Albert, Nathalie L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2aq2vv869fqeig69j3be4dod9g